Testosterone undecanoate for sexual dysfunctions, psychological

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Oct 2023: Trial registered, NCT06082817

The trials

NCT06082817: An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

State
Not started
Phase
Phase 2
People
30 planned
Started
1 Jan 2025
Primary completion
31 Dec 2025
Arms
Active
Results
None posted
  1. 13 Oct 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Andriol, Aveed, Jatenzo, Kyzatrex, Nebido, Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection, Oral Testosterone Undecanoate, Tlando.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.